The effects of an adenosine A(2A) agonist as an adjunctive treatment to alleviate sensorimotor gating deficits in a rodent model of schizophrenia
The adenosine system has become a promising target for the treatment of schizophrenia due to its unique relationship with dopamine D2 receptors. Dopamine D2 receptors display heightened sensitivity in schizophrenia, and inhibition of these receptors has been shown to alleviate some of the psychotic...
Main Author: | Rauhuff, Hannah |
---|---|
Format: | Others |
Published: |
Digital Commons @ East Tennessee State University
2020
|
Subjects: | |
Online Access: | https://dc.etsu.edu/honors/566 https://dc.etsu.edu/cgi/viewcontent.cgi?article=1679&context=honors |
Similar Items
-
DISCOVERY OF A NOVEL ANTI-NEUROINFLAMMATORY TREATMENT FOR AUDITORY SENSORIMOTOR GATING IN TWO RODENT MODELS OF SCHIZOPHRENIA
by: Whicker, Wyatt, et al.
Published: (2018) -
The Effects of an Adenosine A(2A) Agonist on the Rewarding Associative Properties of Nicotine and Neural Plasticity in a Rodent Model of Schizophrenia
by: Gill, W. Drew, et al.
Published: (2019) -
UNDERSTANDING THE ROLE OF OXYTOCIN IN SENSORIMOTOR GATING DEFICITS
by: Dike, Obianuju E.
Published: (2009) -
Neuroanatomical studies of the isolation-reared rat with a deficit in prepulse inhibition of acoustic startle as a model for the sensorimotor gating deficits in schizophrenia
by: Day-Wilson, Katherine Mary
Published: (2004) -
Adjustment of the data acquisition window for the assessment of sensorimotor gating mechanisms in rodents
by: Sebastian Hormigo, et al.
Published: (2019-01-01)